These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 22102818

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.
    Satchidanandam V, Kumar N, Jumani RS, Challu V, Elangovan S, Khan NA.
    PLoS Pathog; 2014 Jun; 10(6):e1004176. PubMed ID: 24945624
    [Abstract] [Full Text] [Related]

  • 5. The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1 /Th17 responses during mycobacteria infection.
    Su H, Peng B, Zhang Z, Liu Z, Zhang Z.
    Mol Immunol; 2019 May; 109():58-70. PubMed ID: 30856410
    [Abstract] [Full Text] [Related]

  • 6. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
    Roche CM, Smith A, Lindsey DR, Meher A, Schluns K, Arora A, Armitige LY, Jagannath C.
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S96-104. PubMed ID: 22082615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
    Luo W, Qu Z, Zhang L, Xie Y, Luo F, Tan Y, Pan Q, Zhang XL.
    Vaccine; 2018 May 17; 36(21):2998-3009. PubMed ID: 29681409
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH, He HY, Zhang BS.
    J Microbiol Immunol Infect; 2014 Feb 17; 47(1):48-56. PubMed ID: 23357605
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.
    J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
    Choi HG, Choi S, Back YW, Paik S, Park HS, Kim WS, Kim H, Cha SB, Choi CH, Shin SJ, Kim HJ.
    Oncotarget; 2017 Mar 21; 8(12):19947-19967. PubMed ID: 28193909
    [Abstract] [Full Text] [Related]

  • 17. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, Fan X.
    Appl Microbiol Biotechnol; 2015 Dec 21; 99(24):10587-95. PubMed ID: 26363555
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6.
    Fan XL, Yu TH, Gao Q, Yao W.
    Acta Biochim Biophys Sin (Shanghai); 2006 Oct 21; 38(10):683-90. PubMed ID: 17033714
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y, Bao L, Yang X.
    Microbiol Immunol; 2011 Nov 21; 55(11):798-808. PubMed ID: 21831202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.